Articles by Jyotsna Ramani
I have done by Post Graduation in Tourism from College of Vocational Studies apart from a full time MBA degree in Finance.I have worked with several reputed companies including IBM, MakeMyTrip and Habitat World. I love to read, write and travel. Currently, I am a SAHM ,earning a living off the stock market and making a killing with forex trades. I am sharing my knowledge so as to help others learn and expand their horizon.
OncoVista Innovative Therapies, Inc (OTC:OVIT) reported that two of their proprietary products, AdnaTest BreastCancer and AdnaTest ETM1/Stem Cell were being evaluated in Germany by the Department of Gynecology and Obstetrics and Internal Medicine at University …
Ziopharm Oncology, Inc. (NASDAQ:ZIOP) has announced today and presented their positive interim data from the multicenter randomized Phase 2 trial of Palifosfamide also known as Zymafos that will be used for the treating patients with …
PPD or Pharmaceutical Product Development, Inc (NASDAQ:PPDI) today announced that they have completed their acquisition of Excel PharmaStudies Inc which is considered to be the market leader and one of the largest contract research organizations …
QuantRx Biomedical Corporation (OTC:QTXB) has announced that the Company will soon demonstrate its latest technology at the MEDICA 2009.
Ligand Pharmaceuticals Inc (NASDAQ:LGND) has announced that they have extended their research collaboration with Pfizer for JAK3 by one year.
MabCure N.V., a subsidiary of MabCure Inc (OTC:MBCI) today announced that they have signed a research agreement with AZ Sint Lucas Hospital in Belgium to conduct preclinical research on its monoclonal antibodies against different cancers. …
Omnicare, Inc. (NYSE:OCR) have announced today that they have gone ahead and finalized the previously disclosed agreement for a voluntary civil settlement with the US Attorney’s Office, District of Massachusetts, the Department of Justice and …
RXi Pharmaceuticals Corporation (NASDAQ:RXII) announced that their Vice President of Technology Development, Dmitry Samarsky will be presenting their new RNAi technology development at the Discovery on Target scientific conference in Boston on November 4, 2009. …
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) today announced that Cancer Cell, one of the leading scientific journals, has published a comprehensive paper describing the design and preclinical characterization of an investigational kinase inhibitor (AP24534).
Enzo Biochem Inc. (NYSE:ENZ) announced today that they have favorable results of the Company’s clinical trial for the treatment of non-alcoholic steatohepatitis.
